The absence of systematic screening for cardiac amyloidosis, particularly wild‐type transthyretin amyloidosis in elderly patients, limits our ability to determine whether RASP reflects myocardial fibrosis, amyloid infiltration, or a combination of both. This evidence concerns the gene TTR and amyloidosis.